The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.
 
Bhavana Bhatnagar
Consulting or Advisory Role - Novartis
Research Funding - Karyopharm Therapeutics (Inst)
 
Alison R. Walker
No Relationships to Disclose
 
Alice S. Mims
Consulting or Advisory Role - Agios
Speakers' Bureau - Novartis
 
Sumithira Vasu
No Relationships to Disclose
 
Rebecca B. Klisovic
No Relationships to Disclose
 
Gregory Behbehani
No Relationships to Disclose
 
James Stewart Blachly
Consulting or Advisory Role - AstraZeneca
 
Karilyn T.M. Larkin
No Relationships to Disclose
 
Meixiao Long
No Relationships to Disclose
 
Qiuhong Zhao
No Relationships to Disclose
 
Parvathi Ranganathan
No Relationships to Disclose
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
William G. Blum
No Relationships to Disclose
 
Ramiro Garzon
No Relationships to Disclose